Medico Remedies Ltd Share Price

Overview

Medico Remedies Ltd share price is currently ₹38.73, down by - ₹1.48 (3.68%) from its previous closing price of ₹40.21. The share price has declined -15.98% over the past month and declined -1.58% over the past year. The stock's 52-week low and high are ₹29.46 and ₹55.02, respectively. Medico Remedies Ltd has a market capitalisation of ₹ 330.00 Cr. The share price was last updated on 08 Sep 2026, 12:50 PM IST.

Medico Remedies Ltd
Medico Remedies Ltd
MEDICO
 0.00
- 1.48
3.68%
Healthcare
 0.00(%)1D

Updated: 08 Sep 2026, 12:50:11 pm IST

Market Data

Open Price

 39.95

Prev. Close

 40.21
 38.26

Day Low

 40.12

Day High

 29.46

52 Week Low

 55.02

52 Week High

HealthcarePharmaceuticals & Drugs
CategorySmall Cap

Fundamentals

Quick Bite

Price To Earnings Ratio

23.33

Sector PE

42.03

PB Ratio

5.14

Sector PB

5.74

EPS

1.66

Dividend Yield

0.00

Today's Volume

162.657 K

5 Day Avg. Volume

225.083 K

PEG Ratio

1.07

Market Cap.

₹ 330.00 Cr.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

Corporate Actions will be available shortly.

Mutual Fund Ownership

Mutual Fund Ownership will be available shortly.

About Medico Remedies Ltd 👋

Medico Remedies Limited is an India-based company, principally engaged in the pharmaceutical business. The Company is involved in the development, manufacture and sale of pharmaceutical and nutraceutical products. It focuses on anti-infective, Beta-Lactams, cephalosporins, antimalarial, antiretroviral, anti-ulcer drugs and antacids, vitamins, hematinic and other supplements. The Company also manufactures and markets capabilities in other drugs such as non-steroidal anti-inflammatory drugs (NSAIDS), antihistaminic, anti-diabetics, cardiovascular drugs, diuretics, anti-epileptics, combination drug kits, syrups and cream and gel for various therapeutic segments. Its products include Doxycycline Capsules, Zenof-400 (Ofloxacin Tablets 400mg), Azithromycin Tablets, Aciclovir Tablets, Cipta Tablets, Cotrimoxazole Tablets, Tos Syrup, Pediatric Co-Trimozole Oral, Med Reactin (Cyproheptadine), and Medivit Syrup, among others. Its syrups include Medivit Syrup and Ferrovit Syrup.

Expert Opinions

Insights from SEBI-registered analysts · updated live

Explore all →
Manish Salvi

Manish Salvi

6 Aug • 10:14 AM · SEBI-Registered Analyst

MOMENTUM MANTRA DAILY RUN-UP 📅 06 August 2026

MOMENTUM MANTRA DAILY RUN-UP 📅 06 August 2026 Opening View Indian markets are likely to open on a positive note, with GIFT Nifty trading near 24,723, up 74.80 points (+0.30%). Supportive global cues and sustained buying interest may keep sentiment positive, while the 24,700–24,800 zone will remain the immediate resistance area to watch. 📈 📈 Market Recap Indian equity benchmarks ended marginally higher in a volatile session after the RBI kept the repo rate unchanged at 5.25% and maintained its neutral policy stance, in line with expectations. However, higher crude oil prices amid renewed geopolitical tensions limited the market's gains. 📈 Nifty Key Levels ▪️ Support: 24,430 | 24,350 ▪️ Resistance: 24,650 | 24,780 💰 FII/DII Flow ▪️ FII: -₹943.42 crore ▪️ DII: +₹2,883.17 crore 📊 Options Positioning ▪️ PCR: 0.91 (Neutral to Slightly Bullish) – Put and Call OI remain relatively balanced, indicating a mildly positive near-term bias. ▪️ Resistance: 24,700–24,800 zone, with the highest Call OI concentration at 24,700, followed by 24,800 and 25,000. ▪️ Support: 24,600–24,500 zone, backed by strong Put OI buildup, with the highest Put OI at 24,600, followed by 24,500 and 24,400. ▪️ Max Pain: 24,550 – Suggests Nifty may gravitate around this level ahead of the weekly expiry. ▪️ Interpretation: PCR at 0.91 indicates a neutral to slightly bullish market structure. As long as Nifty holds above the 24,550–24,600 support zone, the broader positive bias is likely to remain intact. A sustained move above 24,700 could trigger fresh buying towards 24,800–25,000, while a break below 24,550 may lead to profit booking towards 24,500–24,400. Source: NSE India 🏭 Sectoral Outlook 🟢 Bank Nifty – Buy on Dips 🟢 PSU Bank – Buy on Dips 🟢 Metal – Buy on Dips 🟢 Energy – Buy on Dips 🟢 Pharma – Buy on Dips 🟢 Auto – Accumulate 🟡 Realty – Stock Specific 🚫 Stocks in NEWS

WELENT
KOLTEPATIL
JAINREC
⚠️ For informational purposes only. Not investment advice.

See More
DEEPAK PAL

DEEPAK PAL

13 Mar • 9:22 AM · SEBI-Registered Analyst

MARKET OUTLOOK-: "रेंजबाउंड रिकवरी की उम्मीद, मेटल्स-इन्फ्रा पर नजर!"

Indian Stock Market Outlook - March 13, 2026 Today's Indian stock market is likely to remain rangebound sideways after the previous two days' decline, with Gift Nifty signaling a weak opening—Sensex between 76,300-77,400 and Nifty around 23,500-23,800. Global markets show mild weakness (US30 -0.61%, DAX -0.21%) and a strong Dollar Index at 99.75, potentially pressuring exporter stocks. FII & DII Activity (Up to March 12) In March, FIIs sold ₹46,166 crore while DIIs bought ₹60,549 crore. On March 12, FII net sellers at ₹7,050 crore, DII net buyers at ₹7,450 crore. Stocks in Action/News Today Focus Stocks:

JINDALSAW
Jindal Saw (₹199, bullish trend),
JKLAKSHMI
JK Lakshmi Cement,
GRAVITA
Gravita India,
BALAMINES
Balaji Amines,
SHAILY
Shaily Engineering Plastics,
KALPATARU
Kalpataru,
ACE
Action Construction Equipment,
MFSL
Max Financial,
MANORAMA
Manorama Industries,
KPIGREEN
KPI Green Energy. Sector Focus: Metals (Jindal Saw), Cement (JK Lakshmi), Chemicals (Balaji Amines, Shaily), Infra (Kalpataru). IPO Listings: Raajmarg Infra InvIT and Apsis Aerocom may list today (IPO closed March 11-13).
VBL
DMART
HAPPSTMNDS
UCOBANK
PPLPHARMA
ASHOKA
ETERNAL
SWIGGY
Today's Results/Events Q3 FY26 Results: HEM Holdings (235% profit growth), Medico Remedies, LKP Finance, Honda India Power Products. No major Q4 results. Key News/Events: Crude price surge, ongoing FII selling, bullish recommendation on Jindal Saw (target ₹250). No major macro events.
TATAPOWER
CGPOWER
NTPCGREEN
KPIGREEN
ADANIPOWER
NHPC
POWERINDIA
ENRIN

See More
Shashank Gupta

Shashank Gupta

20 Jan • 12:44 PM · SEBI-Registered Analyst

MEDICO
secured a govt. supply order worth 73.23 Cr.

Medico Remedies Limited has received a government supply order worth INR 73.23 crore from Uttar Pradesh Medical Supplies Corporation Limited, a government entity responsible for centralized procurement and distribution of medicines in Uttar Pradesh. The order involves supplying Azithromycin 500mg tablets, with the full delivery to be completed by 31st October 2026. The contract is domestic, has no related party transactions, and the promoter group has no interest in the awarding entity.

See More

News & Events

Frequently Asked Questions

What is the share price of Medico Remedies Ltd?

What is the market cap of Medico Remedies Ltd?

Should I buy Medico Remedies Ltd stock now?

What is the 52 week high and low of Medico Remedies Ltd?

Is the Medico Remedies Ltd stock good to buy?

Is Medico Remedies Ltd a good buy for the long term?

Is Medico Remedies Ltd overvalued or undervalued?

What is the PE and PB ratio of Medico Remedies Ltd?

Start Now